Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Genetics Announces 1-for-30 Reverse Stock Split

NEW YORK – Cancer Genetics on Thursday announced a 1-for-30 reverse stock split of its outstanding common stock, effective at the start of trading on Friday.

In Thursday morning trading on the Nasdaq, the company's shares were down more than 10 percent at $.12.

The Rutherford, New Jersey-based provider of preclinical test systems said that the reverse stock split is intended to increase its stock price to satisfy the $1.00 minimum bid price requirement for continued listing on the Nasdaq.

The reverse stock split will reduce the number of shares of common stock issued and outstanding from about 63 million to about 2.1 million, Cancer Genetics said.

In April, Cancer Genetics announced that its fourth quarter revenues fell 9 percent year over year.

The firm had announced in January that it was looking to raise $3 million in a stock offering that it subsequently closed.

A month earlier, the company said it had cancelled a previously announced planned merger with Jerusalem-based NovellusDx.


The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.